Fundz
Back to Investors

Track Bain Capital Life Sciences's Investment Activity

Get real-time alerts when Bain Capital Life Sciences makes new investments. Full investor profiles, co-investor networks, and deal history are available on Pro plans.

Compare PlansProFull access from $59/mo
B

Bain Capital Life Sciences

Private Equity
Total Deals
21
Recent (90d)
0
Total Capital
$3.5B
Co-Investors
126
I

Imperative Care

convertible note
$100.0M

Mar 17, 2026

S

Syremis Therapeutics

Biotechnology
series a
$165.0M

Dec 18, 2025

K

Kailera Therapeutics

BiotechnologyWaltham, United States
series b
$600.0M

Oct 14, 2025

A

Apreo Health

BiotechnologyMenlo Park, United States
series b
$130.0M

Aug 7, 2025

H

Heartflow, Inc.

BiotechnologyMountain View, United States
convertible note
$98.0M

Jul 18, 2025

16+ more investments

View all 21 deals by Bain Capital Life Sciences

ProFull deal history requires Pro

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. Trusted by firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz tracks 200,000+ companies and 40,000+ investors.